Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PARANOID! TIRED OF TALKING TO YOURSELF? LET'S TALK(TTP) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (72)	5/31/1998 4:27:00 PM
From: Scott H. Davis	Read Replies (2) \| Respond to of 626

Miljenko, Texas & All: Have not seen Pivanex defined in any of the releases I've read. Could anybody explain briefly nature of compound, applications, clinical development & licensing status? Any info will be appreciated. I've requested the IR lit & annual report, but since my buy tarket is at 4.5, I'd love to have this info in advance of the opportunity. Thanks, Scott

To: Miljenko Zuanic who wrote (72)	5/31/1998 5:13:00 PM
From: scaram(o)uche	Read Replies (2) \| Respond to of 626

Miljenko: Yeah, I like the valuation of TTNP for ilo/piv alone. Since the days of Mark Greene, people have been "seeing" antibody induced by anti-id vaccines. I've never seen anything that was of high enough affinity to believe in. Thus far anti-id has largely been the realm of BS artists. I desperately want to be wrong. The concept is elegant, and it would be a marvelous tool against cancer. Just hasn't worked. And, it certainly isn't a new concept. Remember the investment pedigree in this company. Rick